Assessment of the Selenoprotein M (SELM) over-expression on human hepatocellular carcinoma tissues by immunohistochemistry

European Journal of Histochemistry

Volumn 58, Issue 4, 2014, Pages 287-290

  Guerriero, E ^a   Accardo, M ^b   Capone, F ^a   Colonna, G ^b   Castello, G ^a   Costantini, Susan ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Hepatocellular carcinoma; Immunohistochemistry; SELM

Indexed keywords

HEPATITIS C VIRUS;

SELENOPROTEIN; SELM PROTEIN, HUMAN; TUMOR PROTEIN;

AGED; BIOSYNTHESIS; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SELENOPROTEINS;

EID: 84923005458     PISSN: 1121760X     EISSN: 20388306     Source Type: Journal    
DOI: 10.4081/ejh.2014.2433     Document Type: Article

References (24)

1. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-241.
2. Pitts MW, Reeves MA, Hashimoto AC, Ogawa A, Kremer P, Seale LA, et al. Deletion of selenoprotein M leads to obesity without cognitive deficits. J Biol Chem 2013;288:26121-34.
3. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigó R, et al. Characterization of mammalian selenoproteomes. Science 2003;300:1439-1443.
4. Bellinger FP, Raman AV, Reeves MA, Berry MJ. Regulation and function of selenoproteins in human disease. Biochem J 2009;422:11-22.
5. Loef M, Schrauzer GN, Walach H. Selenium and Alzheimer's disease: a systematic review. J Alzheimers Dis 2011;26:81-104.
6. Korotkov KV, Novoselov SV, Hatfield DL, Gladyshev VN. Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element. Mol Cell Biol 2002;22:1402-11.
7. Zhang Y, Zhou Y, Schweizer U, Savaskan NE, Hua D, Kipnis J, et al. Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals. J Biol Chem 2008;283:2427-38.
8. Ferguson AD, Labunskyy VM, Fomenko DE, Araç D, Chelliah Y, Amezcua CA, et al. NMR structures of the selenoproteins Sep15 and SELM reveal redox activity of a new thioredoxin-like family. J Biol Chem 2006;281:3536-43.
9. Martin JM. Thioredoxina fold for all reasons. Structure 1995;3:245-50.
10. Qi Y, Grishin NV. Structural classification of thioredoxin-like fold proteins. Proteins 2005;58:376-88.
11. Hwang DY, Sin JS, Kim MS, Yim SY, Kim YK, Kim CK, et al. Overexpression of human selenoprotein M differentially regulates the concentrations of antioxidants and H2O2, the activity of antioxidant enzymes, and the composition of white blood cells in a transgenic rat. Int J Mol Med 2008;21:169-79.
12. Reeves MA, Bellinger FP, Berry MJ. The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid Redox Signal 2010;12:809-18.
13. Yim SY, Chae KR, Shim SB, Hong JT, Park JY, Lee CY, et al. ERK activation induced by selenium treatment significantly downregulates beta/gamma-secretase activity and Tau phosphorylation in the transgenic rat overexpressing human selenoprotein M. Int J Mol Med 2009;24:91-6.
14. Gollob JA, Wilhelm S, Carter C, Kelley SL. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol 2006;33:392-406.
15. Min L, He B, Hui L. Mitogen-activated protein kinases in hepatocellular carcinoma development. Semin Cancer Biol 2011;21: 10-20.
16. Guariniello S, Colonna G, Raucci R, Costantini M, Di Bernardo G, Bergantino F, et al. Structure-function relationships and evolutionary history of the human selenoprotein M (SELM) found overexpressed in hepatocellular carcinoma. Biochim Biophys Acta 2014;1844:447-56.
17. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41.
18. Zhang X, Zheng Z, Yingji S, Kim H, Jin R, Renshu L, et al. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. Oncol Rep 2014;31:2587-92.
19. Epplein M, Burk RF, Cai Q, Hargreaves MK, Blot WJ. A prospective study of plasma Selenoprotein P and lung cancer risk among low-income adults. Cancer Epidemiol Biomarkers Prev 2014;23:1238-44.
20. Pellatt AJ, Wolff RK, John EM, Torres-Mejia G, Hines LM, Baumgartner KB, et al. SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study. PLoS One 2013;8:e80554.
21. Meyer HA, Endermann T, Stephan C, Stoedter M, Behrends T, Wolff I, et al. Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients. PLoS One 2012;7:e46644.
22. Méplan C, Hesketh J. Selenium and cancer: a story that should not be forgotteninsights from genomics. Cancer Treat Res 2014;159:145-66.
23. Carlson BA, Novoselov SV, Kumaraswamy E, Lee BJ, Anver MR, Gladyshev VN, et al. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem 2004;279:8011-7.
24. Novoselov SV, Calvisi DF, Labunskyy VM, Factor VM, Carlson BA, Fomenko DE, et al. Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene 2005;24:8003-11.